Actinogen Medical Ltd (ACW.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -38 | -8 | -37 | -3 | -6 |
| Investing Cash Flow | $-38 | $-8 | $-37 | $-3 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 12,238 | 19,106 | 903 | 13,322 | 10,911 |
| Common Stock Repurchased | -530 | -1,064 | N/A | -831 | -716 |
| Other Financing Activity | -61 | -92 | -78 | -71 | -84 |
| Financing Cash Flow | $14,647 | $17,950 | $825 | $12,420 | $10,111 |
| Exchange Rate Effect | N/A | N/A | N/A | 13 | N/A |
| Beginning Cash Position | 9,451 | 8,460 | 16,370 | 13,422 | 5,040 |
| End Cash Position | 16,504 | 9,451 | 8,460 | 16,370 | 13,422 |
| Net Cash Flow | $7,053 | $991 | $-7,910 | $2,900 | $8,381 |
| Free Cash Flow | |||||
| Capital Expenditure | -38 | -8 | -37 | -3 | -6 |
| Free Cash Flow | -38 | -8 | -37 | -3 | -6 |